Understanding the Impact of Alzheimer’s on the Sense of Smell

Alzheimer’s disease is a complex condition that remains not fully understood, but scientists have made significant progress in understanding how it affects the senses, particularly the sense of smell. A recent study indicates that immune cells in the brain, known as “microglia,” play a role in the deterioration of neural connections between two key brain regions, leading to olfactory disorders in patients.

The Role of Microglia

Researchers have found that microglia remove the connections between the olfactory bulb and the locus coeruleus in the brain. The olfactory bulb, located in the forebrain, analyzes sensory information from olfactory receptors in the nose. Meanwhile, the locus coeruleus, located in the brainstem, influences this process through long nerve fibers.

The locus coeruleus is responsible for regulating various physiological mechanisms such as blood flow to the brain, sleep-wake cycles, and sensory processing, including the sense of smell. The study suggests that changes in the nerve fibers connecting the locus coeruleus and the olfactory bulb occur in the early stages of Alzheimer’s disease, signaling to microglia that the affected fibers may be defective, leading to their dismantling.

Changes in Membrane Composition

The research team, led by Dr. Lars Beiger and Professor Jochen Herms, discovered changes in the composition of the membranes of affected nerve fibers, where phosphatidylserine, a fatty acid, is transferred from the inner to the outer layer of the cell membrane. The presence of phosphatidylserine on the outer membrane surface is known as a signal for microglia to perform a process called synaptic pruning.

Researchers hypothesize that this change in membrane composition results from hyperactivity in the affected nerves due to Alzheimer’s disease, leading to abnormal nerve signal release.

Diverse Data

The study’s findings are based on a wide range of observations, including studies on mice exhibiting Alzheimer’s symptoms, analysis of brain samples from deceased Alzheimer’s patients, and positron emission tomography scans of individuals with mild cognitive impairments.

Olfactory problems in Alzheimer’s and the associated nerve damage have been a topic of discussion for a long time, but the causes have remained unclear until now. The current research suggests that an immune mechanism may be responsible for these disorders, particularly in the early stages of the disease.

Prospects for Early Diagnosis

Recently developed beta-amyloid antibodies for treating Alzheimer’s need to be applied in the early stages of the disease to be effective. The current study suggests the possibility of identifying patients at risk of developing Alzheimer’s early, allowing for comprehensive testing to confirm the diagnosis before cognitive problems appear.

This could enable early intervention using beta-amyloid antibodies, increasing the likelihood of a positive response to treatment.

Conclusion

The study of the role of microglia and changes in neural membrane composition is a significant step toward a deeper understanding of how Alzheimer’s affects the senses, particularly smell. This research opens the door to more accurate diagnosis in the early stages of the disease, offering better opportunities for treatment and early intervention. Further studies are needed to confirm these findings, but there is hope for improving patients’ quality of life in the future.